Home/Filings/4/0001181431-13-054170
4//SEC Filing

SAVIENT PHARMACEUTICALS INC 4

Accession 0001181431-13-054170

CIK 0000722104operating

Filed

Oct 16, 8:00 PM ET

Accepted

Oct 17, 1:17 PM ET

Size

14.5 KB

Accession

0001181431-13-054170

Insider Transaction Report

Form 4
Period: 2013-10-15
Hamill John
SVP, CFO
Transactions
  • Sale

    Common Stock

    2013-10-15$0.08/sh5,000$39697,113 total
  • Sale

    Common Stock

    2013-10-15$0.08/sh1,500$119102,113 total
  • Sale

    Common Stock

    2013-10-15$0.08/sh7,646$61266,667 total
  • Sale

    Common Stock

    2013-10-15$0.08/sh1,000$8075,113 total
  • Sale

    Common Stock

    2013-10-15$0.08/sh21,000$1,67076,113 total
  • Sale

    Common Stock

    2013-10-15$0.08/sh800$6474,313 total

Issuer

SAVIENT PHARMACEUTICALS INC

CIK 0000722104

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000722104

Filing Metadata

Form type
4
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 1:17 PM ET
Size
14.5 KB